The global blood bank market size is estimated at USD 18.58 billion in 2024, grew to USD 19.26 billion in 2025 and is predicted to surpass around USD 26.61 billion by 2034, expanding at a CAGR of 3.66% between 2024 and 2034. The North America blood bank market size accounted for USD 8.36 billion in 2024 and is anticipated to grow at a fastest CAGR of 3.77% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Blood Bank Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Blood Bank Market, by Product, 2024-2034
8.1.1. Whole Blood
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Red Blood Cells
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Platelets
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Plasma
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. White Blood Cells
8.1.5.1. Market Revenue and Forecast (2021-2034)
9.1. Blood Bank Market, by Function, 2024-2034
9.1.1. Collection
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Processing
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Testing
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Storage
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Transportation
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Blood Bank Market, by Bank Type, 2024-2034
10.1.1. Private
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Public
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. Blood Bank Market, by End User, 2024-2034
11.1.1. Hospital
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Ambulatory Surgery Centers
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Pharmaceutical Companies
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Clinics and Nursing Homes
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2034)
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.2. Market Revenue and Forecast, by Function (2021-2034)
12.1.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.1.4. Market Revenue and Forecast, by End User (2021-2034)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.5.2. Market Revenue and Forecast, by Function (2021-2034)
12.1.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.1.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.1.6.2. Market Revenue and Forecast, by Function (2021-2034)
12.1.6.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.1.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.2. Market Revenue and Forecast, by Function (2021-2034)
12.2.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.2.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.5.2. Market Revenue and Forecast, by Function (2021-2034)
12.2.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.2.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.6.2. Market Revenue and Forecast, by Function (2021-2034)
12.2.6.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.2.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.7.2. Market Revenue and Forecast, by Function (2021-2034)
12.2.7.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.2.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.2.8.2. Market Revenue and Forecast, by Function (2021-2034)
12.2.8.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.2.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.2. Market Revenue and Forecast, by Function (2021-2034)
12.3.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.3.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.5.2. Market Revenue and Forecast, by Function (2021-2034)
12.3.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.3.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.6.2. Market Revenue and Forecast, by Function (2021-2034)
12.3.6.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.3.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.7.2. Market Revenue and Forecast, by Function (2021-2034)
12.3.7.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.3.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.3.8.2. Market Revenue and Forecast, by Function (2021-2034)
12.3.8.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.3.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.2. Market Revenue and Forecast, by Function (2021-2034)
12.4.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.4.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.5.2. Market Revenue and Forecast, by Function (2021-2034)
12.4.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.4.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.6.2. Market Revenue and Forecast, by Function (2021-2034)
12.4.6.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.4.6.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.7.2. Market Revenue and Forecast, by Function (2021-2034)
12.4.7.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.4.7.4. Market Revenue and Forecast, by End User (2021-2034)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
12.4.8.2. Market Revenue and Forecast, by Function (2021-2034)
12.4.8.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.4.8.4. Market Revenue and Forecast, by End User (2021-2034)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.2. Market Revenue and Forecast, by Function (2021-2034)
12.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.5.2. Market Revenue and Forecast, by Function (2021-2034)
12.5.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.5.5.4. Market Revenue and Forecast, by End User (2021-2034)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2034)
12.5.6.2. Market Revenue and Forecast, by Function (2021-2034)
12.5.6.3. Market Revenue and Forecast, by Bank Type (2021-2034)
12.5.6.4. Market Revenue and Forecast, by End User (2021-2034)
13.1. America's Blood Centers
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Australian Red Cross Society
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Blood Bank of Alaska
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Canadian Blood Services
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Japanese Red Cross Society
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. New York Blood Center
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Sanquin Blood Supply Foundation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. The American Red Cross
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Vitalant
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. NHS Blood and Transplant
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample